文献速递血管炎

抗中性粒细胞胞质抗体相关性血管炎中的甲状腺疾病:一项临床与流行病学研究

Thyroid disease in ANCA-associated vasculitis: a clinical and epidemiological study.
PubMed 文献 · RMD Open · 2024-04-30

该研究纳入瑞典南部人群队列325例和英国剑桥血管炎专科中心队列319例共644例抗中性粒细胞胞质抗体(ANCA)相关性血管炎(AAV)患者,回顾病历确认AAV与甲状腺疾病(TD)诊断。AAV诊断时100例(15.5%,77例女性)已患TD,随访4522人年新发TD 29例,发病率641/10万人年,未发现可预测新发TD的因素。

要点

  • AAV诊断时15.5%患者已患甲状腺疾病,瑞典南部AAV患者甲状腺疾病患病率为18%。
  • 随访期间甲状腺疾病发病率为641/10万人年,未发现可预测新发甲状腺疾病的因素。
  • 合并甲状腺疾病的AAV患者总生存和肾脏生存更高。

核心结论

  • 甲状腺疾病是AAV常见合并症,影响近五分之一患者;女性及MPO-ANCA+者诊断时更常见,但这些因素不能预测AAV治疗开始后的新发甲状腺疾病,需对所有AAV患者监测该合并症。

研究设计与样本

  • 研究纳入644例AAV患者,包括瑞典南部人群队列325例和英国剑桥血管炎专科中心队列319例,AAV与甲状腺疾病诊断及分类均经病历复核确认。
  • 随访人年从AAV诊断计算至甲状腺疾病、死亡或研究结束中最早发生者,采用Cox回归分析甲状腺疾病预测因素。

主要发现

  • AAV诊断时100例(15.5%,77例女性)患有甲状腺疾病,其中59例MPO-ANCA+、34例PR3-ANCA+。
  • 合并甲状腺疾病的AAV患者倾向于C反应蛋白较低、血红蛋白较低、全身症状较少。
  • 合并甲状腺疾病的AAV患者总生存和肾脏生存更高。
  • 随访4522人年期间新发甲状腺疾病29例,发病率为641/10万人年。
  • 未发现所分析因素可预测AAV患者新发甲状腺疾病;瑞典南部AAV患者甲状腺疾病患病率为18%。

临床怎么用

  • 原文结论指出需对所有AAV患者监测甲状腺疾病这一合并症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe clinical and laboratory characteristics and outcomes in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and thyroid disease (TD). We also aimed to calculate incidence and identify predictors of TD in two large cohorts of patients with AAV. METHODS: The study comprised 644 patients with AAV in a population-based cohort from southern Sweden (n=325) and a cohort from a specialised vasculitis centre in Cambridge, UK (n=319). Diagnosis and classification of AAV and TD were confirmed by medical record review. Person-years (PY) of follow-up were calculated from AAV diagnosis to the earliest of TD, death or the end of study. Cox-regression analysis was employed to study predictors of TD. RESULTS: At AAV diagnosis, 100 individuals (15.5%, 77 females) had TD, 59 had myeloperoxidase (MPO)-ANCA+ and 34 had proteinase-3 (PR3)-ANCA+. Patients with TD tended to have lower C reactive protein, lower haemoglobin and fewer constitutional symptoms. Survival and renal survival was greater in those patients with AAV with pre-existing TD. During 4522 PY of follow-up, a further 29 subjects developed TD, yielding an incidence rate of 641/100 000 PY. No analysed factor predicted de novo TD in AAV. The prevalence of TD among patients with AAV in southern Sweden was 18%. CONCLUSION: TD is a common comorbidity in AAV, affecting nearly one in five. While TD diagnosis is more common in females and MPO-ANCA+, these factors do not predict de novo TD after initiation of AAV treatment, necessitating monitoring of all patients with AAV with respect to this comorbidity.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Wilding A, Smith R, Jayne D, et al. Thyroid disease in ANCA-associated vasculitis: a clinical and epidemiological study. RMD Open. 2024. PMID: 38688691. doi:10.1136/rmdopen-2023-003996

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。